TFF Pharmaceuticals Inc. - Nilai perusahaan marang volume dodolan TFFP

Logo perusahaan publik tffpharma.com (TFFP)

Does TFF Pharmaceuticals (TFFP) have a future now that the business liquidation is nearly complete? Optimism was driven by US-based CMO outsourcing sites developing inhalation drugs, but the EV-to-revenue multiple indicates a dangerous overvaluation. The value of captures the metric level amid risks of technological substitution and the slow adoption of freeze-drying by partners, which is crashing the capitalization.

TFF Pharmaceuticals Inc. - Rasio nilai perusahaan marang pendapatan TFFP (periode 04.07.2022 - 20.11.2026)

TFF Pharmaceuticals Inc. - rincian analitis lan metrik utama (TFFP)

Analisis wiwitan perusahaan:tffpharma.com TFFP
Sampel barang TFF Pharmaceuticals, Inc.

The EV/Sales metric determines the total enterprise value, including debt, per unit of revenue, allowing for an assessment of the market premium paid for the generated cash flow. By analyzing historical EV/Sales levels, an investor can correlate the valuation of TFF Pharmaceuticals (TFFP) with the potential of its innovative technology for converting drugs into powder form for inhalation, which expands partnerships with global pharma behemoths.

Analisis pesaing

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales AMRX|Rasio total nilai perusahaan marang pendapatan Perrigo Company plc|Multiplikator EV/Sales ALVO (Alvotech Biopharmaceuticals)|LQDA: Rasio nilai perusahaan marang pendapatan|Galapagos N.V. - Multiplikator EV/Sales|ANIP - Multiplikator EV/Sales|MNKD: Multiplikator EV/Sales|amphastar.com (AMPH) - Multiplikator EV/Sales|PCRX (Pacira Pharmaceuticals) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan ARS Pharmaceuticals, Inc. (SPRY)|Multiplikator EV/Sales TBPH|AQST (Aquestive Therapeutics) - Nilai bisnis marang pendapatan|scPharmaceuticals, Inc. - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan TECX|tonixpharma.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan BioHarvest|Nilai perusahaan marang pendapatan EXOZ|Nilai perusahaan marang pendapatan Oramed Pharmaceuticals (ORMP)|Nilai perusahaan marang pendapatan ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABVC (ABVC BioPharma Inc)|CPIX - Nilai perusahaan marang pendapatan|Quantum BioPharma Corp - Multiplikator EV/Sales|FGEN (fibrogen.com) - Rasio nilai perusahaan marang pendapatan|TELO (Telomir Pharmaceuticals) - Nilai perusahaan marang pendapatan|Rani Therapeutics Holdings - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan SNYR|Multiplikator nilai perusahaan marang pendapatan rallybio.com RLYB|Multiplikator EV/Sales LEXX|PULM (Pulmatrix, Inc.) - Nilai bisnis marang pendapatan|Pheton Holdings - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales Aptorum Group Limited APM|LYRA: Nilai perusahaan marang pendapatan|IBO: Rasio nilai perusahaan marang pendapatan|TNFA: Multiplikator EV/Sales|YCBD: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan PainReform Ltd|CYTO (altamiratherapeutics.com) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIPO|OPTN - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan pieris.com PIRS|Nilai bisnis marang pendapatan PROC|PTPI - Rasio nilai perusahaan marang pendapatan|Qilian International Holding (QLI) - Nilai perusahaan marang pendapatan|SLRN: Multiplikator EV/Sales